We provide 360 integrated field and marketing solutions across 17 European countries, delivering measurable results for consumer electronics, IT, telecommunications, sports, health and beauty and automotive brands
Lower doses of GLP-1 RA are typically used for glycaemic control than in weight loss
GLP-1 Agonists Pipeline Development Activities The GLP-1 agonists therapeutics market report covers information on collaborations, acquisitions and mergers, licensing, and patent details for Glucagon-like Peptide-1 (GLP-1) Agonists
Neurological impact of vitamin B12 deficiency
According to Horn and colleagues and Milushewa and colleagues, factors such as initial A1C level, adherence to medication, and other underlying health conditions can influence actual A1C reduction
What does the peptide Epitalon do